Biopharma Group Case Study: Lyophilized Oligonucleotide Drug Product Cycle Optimization & Risk Assessment Using Quality by Design (QbD)
July 18, 2024
Application Note: Addressing the Challenges of Lyobead Production
July 23, 2024Biopharma Group Case Study - Lyophilized Beads for Injectables
ABSTRACT:
A leading pharmaceutical manufacturer approached Biopharma Group (BG) to develop a bead-format solution for the injectable product. The objective was to achieve robust lyobeads with a consistent size, which would enable the product to have a longer shelf life. Various excipients were proposed, and, after initial screening, four candidate formulations were design
Written by Biopharma Group's Niloofar Ganji MSc, this case study outlines how the challenge was tackled along with the subsequent results and conclusions.
Download here to discover more
